- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Institutional Culture and Sensitive Investigations
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Matthew A. Krimski
News 17 results
In the News · Source: The Deal
October 25, 2024
K&S advises Eagle Merchant Partners on its acquisition of a majority stake in Sam the Concrete Man
Cases & Deals
October 23, 2024
King & Spalding Represented Eagle Merchant Partners in Its Acquisition of a Majority Stake in SamCo
Cases & Deals
April 9, 2024
King & Spalding advises Dude Perfect in connection with Strategic Partnership with Highmount Capital
In the News · Source: The Hollywood Reporter, Deadline, Law360, SportsPro and Global Legal Chronicle
April 9, 2024
K&S advises Dude Perfect in connection with its strategic partnership with Highmount Capital
In the News · Source: The Texas Lawbook and Global Legal Chronicle
December 12, 2023
Mitch Tiras, James Larkin Smith and Matthew Krimski advise NGP on its $150M capital commitment to Segue Renewables II
Cases & Deals
October 27, 2023
King & Spalding Advises Rotomaster on its Sale to Cloyes
In the News · Source: Global Legal Chronicle
September 27, 2023
K&S advises SERMA on its acquisition of Microtech Laboratories
In the News · Source: Global Legal Chronicle
September 8, 2023
K&S advises Mativ on the $620M proposed sale of its Engineered Papers business to Evergreen Hill Enterprise
Cases & Deals
September 5, 2023
King & Spalding Acts For SERMA on Acquisition of Microtech Laboratories
Cases & Deals
August 1, 2023
Mativ Holdings Announces Proposed Sale of its Engineered Papers Business for $620 Million
Cases & Deals
July 3, 2023
Somnoware Healthcare Systems Acquired by ResMed Digital Health (NYSE: RMD)
In the News · Source: Law360 and The Deal
March 24, 2023
K&S advises the special committee of the board of directors of U.S. Xpress in its $808M acquisition by Knight-Swift Transportation